The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions

The potential effectiveness of Nigella sativa oil (NSO) has been shown in patients with diabetic neuropathy. However, its safety profiles in this group of patients remain underexplored. This study aimed to evaluate the hematological and biochemical safety profiles of NSO in this population. A single...

Full description

Bibliographic Details
Main Authors: Syuhada, Anggadiredja, Kusnandar, Kurniati, Neng Fisheri, Akrom
Format: Article
Language:English
Published: Penerbit Universiti Kebangsaan Malaysia 2025
Online Access:http://journalarticle.ukm.my/25988/
http://journalarticle.ukm.my/25988/1/SML%2010.pdf
_version_ 1848816499947470848
author Syuhada,
Anggadiredja, Kusnandar
Kurniati, Neng Fisheri
Akrom,
author_facet Syuhada,
Anggadiredja, Kusnandar
Kurniati, Neng Fisheri
Akrom,
author_sort Syuhada,
building UKM Institutional Repository
collection Online Access
description The potential effectiveness of Nigella sativa oil (NSO) has been shown in patients with diabetic neuropathy. However, its safety profiles in this group of patients remain underexplored. This study aimed to evaluate the hematological and biochemical safety profiles of NSO in this population. A single-center clinical trial was conducted involving 24 patients with diabetic neuropathy who received NSO at a dose of 2 mL/day for 30 days. Hematological and biochemical parameters were assessed before and after intervention. The hematological parameters included hemoglobin (HGB), white blood cell (WBC) count, red blood cell (RBC) count, hematocrit (Hct), and platelet (Plt) count. Meanwhile, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatinine were measured representing hepatorenal parameters. Other adverse events accompanying NSO supplementation were also recorded. The results showed no significant changes in hematological parameters or hepatorenal function markers. A slight increase in mean corpuscular hemoglobin concentration (p = 0.0483) was observed, but values remained within normal physiological limits. Other adverse events reported were categorized non-serious, except one transient case of tachycardia that resolved without clinical consequences. The findings suggest that NSO is safe for patients with diabetic neuropathy. Further long-term studies with larger sample sizes are recommended to confirm these results.
first_indexed 2025-11-15T01:06:51Z
format Article
id oai:generic.eprints.org:25988
institution Universiti Kebangasaan Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T01:06:51Z
publishDate 2025
publisher Penerbit Universiti Kebangsaan Malaysia
recordtype eprints
repository_type Digital Repository
spelling oai:generic.eprints.org:259882025-10-13T07:57:25Z http://journalarticle.ukm.my/25988/ The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions Syuhada, Anggadiredja, Kusnandar Kurniati, Neng Fisheri Akrom, The potential effectiveness of Nigella sativa oil (NSO) has been shown in patients with diabetic neuropathy. However, its safety profiles in this group of patients remain underexplored. This study aimed to evaluate the hematological and biochemical safety profiles of NSO in this population. A single-center clinical trial was conducted involving 24 patients with diabetic neuropathy who received NSO at a dose of 2 mL/day for 30 days. Hematological and biochemical parameters were assessed before and after intervention. The hematological parameters included hemoglobin (HGB), white blood cell (WBC) count, red blood cell (RBC) count, hematocrit (Hct), and platelet (Plt) count. Meanwhile, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatinine were measured representing hepatorenal parameters. Other adverse events accompanying NSO supplementation were also recorded. The results showed no significant changes in hematological parameters or hepatorenal function markers. A slight increase in mean corpuscular hemoglobin concentration (p = 0.0483) was observed, but values remained within normal physiological limits. Other adverse events reported were categorized non-serious, except one transient case of tachycardia that resolved without clinical consequences. The findings suggest that NSO is safe for patients with diabetic neuropathy. Further long-term studies with larger sample sizes are recommended to confirm these results. Penerbit Universiti Kebangsaan Malaysia 2025 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/25988/1/SML%2010.pdf Syuhada, and Anggadiredja, Kusnandar and Kurniati, Neng Fisheri and Akrom, (2025) The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions. Sains Malaysiana, 54 (8). pp. 1995-2006. ISSN 0126-6039 https://www.ukm.my/jsm/english_journals/vol54num8_2025/contentsVol54num8_2025.html
spellingShingle Syuhada,
Anggadiredja, Kusnandar
Kurniati, Neng Fisheri
Akrom,
The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions
title The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions
title_full The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions
title_fullStr The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions
title_full_unstemmed The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions
title_short The safety profiles of Nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions
title_sort safety profiles of nigella sativa oil as a supplement in diabetic neuropathy patients: assessment on hematology and hepatorenal functions
url http://journalarticle.ukm.my/25988/
http://journalarticle.ukm.my/25988/
http://journalarticle.ukm.my/25988/1/SML%2010.pdf